Member Info for mulledwine

Exclusive Distribution Agreement for CarieScan PRO in India 3D, the developer and supplier of the CarieScan PRO, the award winning hand held device for the early detection and monitoring of dental caries (tooth decay) is pleased to announce that its subsidiary CarieScan Limited has signed an exclusive distribution agreement for India with Analytical and Medical Technologies ("AMT"). This follows the announcement last week of an agreement with Wisdom International Medical Science and Technology Co. Ltd for the Chinese Market. AMT has 40 direct employees and distributes its products through 28 sub dealers across the country. The company has its main office located in Mumbai with a further 9 regional offices. AMT specialises in the importation of innovative high technology dental products from around the world. Training dental personnel on the use of these products is a key element of AMT's business success. The company has good contacts with the 270 dental colleges registered in India. The expansion of dental education has been enormous over the past 10 years and in the coming years a further 27,000 new dentists (a number broadly equivalent to the number of dentists currently in practice in the UK) are anticipated to qualify out of the dental schools each year. Most of these dentists are expected to progress into private practice to meet the healthcare needs of an increasingly affluent Indian society. No additional regulatory approvals are required for the CarieScan PRO to be offered for sale in India and an initial 30 units are expected to be shipped in the near future.

http://www.halifaxmarketwatch.co.uk/rns.cgi?username=&ac=&action=news&rns=1&view=full&story_id=4180222

Sergio Morandi, the Company's CEO, stated: "The Guendalina development is entering the most exciting phase, with the development project remaining on schedule and progressing well. The Guendalina development represents one of the key milestones of the Company's business plan that from the point of 'first gas' is expected to generate significantly higher net gas production and revenues than those currently realised by the Company."

Background: The Guendalina gas field is located 47 km off of the northeast coast of Italy in 42 meters of water, outside the offshore restricted area for E&P activities, which was introduced in August 2010 by the Italian Government. ENI has independently certified 2P gas reserves of 22 Bcf (4.5 Bcf net MOG). An additional 5 Bcf (1.0 Bcf net MOG) of potential gas resources will be assessed during the current development drilling campaign by the Gue 2D well. Based on studies performed by ENI, the aggregate gas production from the field is expected to be around 20 MMcf/day (100% basis); 4MMcf/day net to the Company. Funding As announced on 3 March 2011 it is necessary for the Company to raise further funds to develop and progress its exploration, development and producing assets, as well as to meet the Company's working capital requirements. Negotiations for funding are on-going and the Company is hopeful it can conclude an agreement to resolve the Company's financial position satisfactorily. There can be no certainty that these discussions will result in a satisfactory outcome.

Operational Update The Board of Mediterranean Oil & Gas Plc (AIM: MOG), the central Mediterranean focussed producer, developer and explorer of oil and gas assets, is pleased to provide the following operational update on the Guendalina Gas Field. Italy - Concession AC 35 AG - Guendalina Gas Field (MOG interest 20%, ENI 80% and Operator) The Operator, ENI, has informed the Company that following the installation of the platform jacket which was successfully completed in March, the Transocean jack up rig ,"GSF Key Manhattan", commenced drilling of the two development wells Guendalina 2D ("Gue 2D") and Guendalina 3 ("Gue 3") on 7th April 2011 . The two wells are being drilled in parallel, by implementation of the "skid drilling" technique. To date: · the Gue 2D well has been drilled to a depth of 400 meters. The set up of the casing has been completed. · The Gue 3 well has been drilled to a depth of 350 meters. The set up of the casing is ongoing. The planned total depth of the Gue 2D well is 3,290 meters (3,225 meters true vertical depth) , while the planned total depth of the Gue 3 well is 3,190 meters. The Pliocene gas sand levels are expected to be encountered from a depth of about 3,000 meters. ENI estimates that the drilling campaign, including completion of the two wells for production, will be completed by the end of July 2011. In parallel, the construction of the platform deck is progressing. Its installation is forecast to occur immediately after the completion of the development drilling phase. Based on the information received from ENI, the Guendalina field development plan is progressing on schedule and "first gas" is forecast in September 2011. Pictures of the launch, installation of the jacket and the construction of the deck can be viewed on the Company's website.

http://www.halifaxmarketwatch.co.uk/rns.cgi?username=&ac=&action=news&rns=1&view=full&story_id=4180239

Scott McGregor, Camco CEO, said: "Camco has seen an excellent start to the new year with growth in both our Pre 2012 and Post 2012 portfolio volumes, a remarkable success for our origination business. The increasing forward price curve provides good prospects."

Carbon Project Development Update 31 March 2011 Camco, a global developer of emission reductions and clean energy projects, is pleased to provide the following carbon project development update as at 31 March 2011. Portfolio Highlights - Carbon tonnes in Portfolio (compared to last update 30 Sept 10): o Pre 2012 in specie 26.6 million (3% increase) o Post 2012 in specie 36.2 million (33% increase) - Progress: o In specie portfolio registered 2.7 million tonne increase on 30 Sept 10 (13% increase) o Total 70% Pre 2012 in specie portfolio now registered - Delivery: 3.4 million tonnes delivered in Q1 2011 (26% increase on Q4 2010 last update) Carbon Price - EU-ETS eligible emission reductions as at 31 Mar 11 were trading with a forward curve for CERs starting at €13 per tonne for Dec-2011 delivery, increasing to €17 per tonne for Dec-2020 delivery; on average forward contracts prices are up 19% over the quarter* - Camco's weighted average purchase price remains stable at €8.58 per tonne for future delivery of the pre-2012 portfolio

http://www.halifaxmarketwatch.co.uk/rns.cgi?username=&ac=&action=news&rns=1&view=full&story_id=4180242

GGG's listing on ASX has been delayed as a result of difficulties in obtaining endorsement from Auzex of GGG's proposed future expenditure program for the Bullabulling Joint Venture in relation to the Bullabulling Gold Project. As a result, GGG has extended its current application to list on ASX, with its offer under its prospectus now scheduled to close on 2 May 2011. Auzex's lack of co-operation towards GGG's listing in Australia influenced GGG to announce the Offer with a view to ensuring, going forward, that the interests of stakeholders in the Bullabulling Gold Project are aligned through a unified decision-making process rather than being fragmented under the existing corporate decision-making process. If GGG successfully lists on ASX, this will provide the merged entity with access to capital markets in the United Kingdom as well as Australia and GGG Shareholders will have the benefit of a company which is dual-listed with trading in shares on AIM and CHESS Depositary Interests (CDIs) on ASX. If the Offer is successful and GGG successfully lists on ASX, Auzex shareholders who accept the Offer and become GGG shareholders will have the option of trading their GGG shares on AIM or trading GGG CDI's on ASX. Based on the closing price of GGG Shares on AIM and Auzex Shares on ASX on the last trading day prior to the announcement of the Offer,(1) the Offer represents an implied value of A$0.87 per Auzex Share(2) (total equity value circa A$94.9 million)(3) and a premium of: -- 39.3% to Auzex's closing share price on the ASX of A$0.625 on 11 March 2011, using GGG's closing share price on AIM on 11 March 2011 of A$0.6224; -- 21.2% to Auzex's one month VWAP on the ASX of A$0.672 to 11 March 2011, using GGG's one month VWAP on AIM to 11 March 2011 of A$0.5814; -- 10.7% to Auzex's three month VWAP on the ASX of A$0.596 to 11 March 2011, using GGG's three month VWAP on AIM to 11 March 2011 of A$0.4714. -- The Offer is conditional upon GGG becoming entitled to at least 50.1% of Auzex's Shares and certain other conditions included in the Bidder's Statement.

LONDON, UNITED KINGDOM--(Marketwire - April 18, 2011) - Western-Australian mining exploration and development company, GGG Resources plc (GGG) (AIM:GGG), has lodged its Bidder Statement in relation to its off-market takeover offer for all of the fully paid ordinary shares in the capital of Auzex Resources Limited (Auzex) which GGG does not own. GGG has also lodged a fourth supplementary prospectus in relation to its proposed admission to the official list of the Australian Securities Exchange with the Australian Securities and Investment Commission (ASIC). Copies of both documents are available to download from the Company's website www.gggresources.com, and today's release should be read in conjunction with those documents. GGG is currently Auzex's second largest shareholder holding 8,000,000 shares representing approximately 8.42% of Auzex's current fully paid ordinary share capital. Under GGG's offer, Auzex shareholders will, subject to the terms and conditions of the offer, receive seven (7) fully paid ordinary shares in the capital of GGG (GGG Shares) for every five (5) of fully paid ordinary shares in the capital of Auzex (Auzex Shares) they hold (the Offer). GGG's Offer The directors of GGG believe the Offer is a compelling proposition for Auzex shareholders and believe that if the Offer is successful, it will: -- consolidate the ownership of the Bullabulling Gold Project into a single corporate group which will focus on the Bullabulling Gold Project; -- rationalise future decision-making processes in relation to the Bullabulling Gold Project; -- allow for the potential improvement of the efficiency and timeliness in the development of the Bullabulling Gold Project to maximise shareholder value by accelerating exploration and development; -- align the interests of the two shareholder groups into a like-minded, single group of shareholders; -- reduce corporate overheads and duplicated roles; -- allow GGG to appoint a Western Australian based team which will manage the development and operations of the Bullabulling Gold Project in the future; and -- potentially provides the merged entity with greater access to capital markets in the United Kingdom as well as Australia.

http://www.halifaxmarketwatch.co.uk/rns.cgi?username=&ac=&action=news&rns=1&view=full&story_id=4180162

Dr Raymond F. Akers, Jr., Executive Chairman, commented: "We believe that the Breath Asthma Check embodies everything that a good point of care test should be. It can be performed just about anywhere, it does not involve complex instrumentation or require technically sophisticated personnel, and its cost to the end user will be relatively inexpensive. However, the real power of this product is what it can do for millions of people that perhaps have a persistent cough, or trouble with waking up during sleep, or persistent allergic rhinitis, but ignore these symptoms. These people may have underlying asthma, and this easy to perform test could positively impact their lives."

Akers Biosciences, Inc (AIM:AKR), a leading designer and manufacturer of rapid diagnostic screening and testing products, is pleased to announce that clinical trials have commenced for the Company's Breath Asthma Check rapid assay (the "Trials") in Clearwater, FL, USA. The trials have been designed to provide the clinical information to be included in a submission for regulatory approvals for the test in the USA and EU, which ABI intends to submit towards the end of Q3 2011. The Breath Asthma Check rapid assay is a rapid manual assay designed to diagnose asthma at the point of care. It is a non-invasive, disposable detector, designed for one-time use, and is based on the Company's proprietary MicroParticle Catalyzed Biosensor Technology. The test is the seventh product in an expanding portfolio of breath condensate tests. The Breath Asthma Check provides an indication of the acidity/alkalinity of exhaled breath condensate, which has been shown to be a reproducible assay of airway acidity. Airway acidification is associated with airway inflammation, which plays an important role in the pathogenesis of asthma. The Breath Asthma Check has been designed to be a reliable determination of this biomarker in exhaled breath condensate in patients suspected of asthma and could provide an inexpensive, rapid screening aid in the diagnosis of asthma at the earliest stages, to facilitate intervention and treatment. In addition, it may also serve as a compliance tool for physicians to ensure successful drug therapy regimens. Existing methods to diagnose asthma include pulmonary function tests, such as spirometry and bronchial challenge testing, and a point of care instrument. These methods are expensive, time-consuming, and require sophisticated medical personnel. In addition, the pulmonary function tests often do not identify the underlying inflammation of the disease. By contrast, the Breath Asthma Check detector contains indicator chemistry which will undergo a simple colour change in the presence of biomarkers for asthma in the exhaled breath condensate collected from a test subject. The Trials are expected to comprise at least 200 subjects with mild, moderate and severe asthma as well as controlled and uncontrolled subjects. The Trials are being conducted in partnership with Innovative Research of West Florida. Innovative Research is an experienced clinical research organization involved in clinical trials for pharmaceutical and medical device companies.

http://www.halifaxmarketwatch.co.uk/rns.cgi?username=&ac=&action=news&rns=1&view=full&story_id=4180189

Released late Friday - so down today then?

The traditional slow start in January combined with the introduction of revised support methods resulted in a significant decrease in production for the quarter. We are confident that the impact of this is short term and that production will return to anticipated levels. Development at Crocette is progressing, and in the Eastern Limb we anticipate awarding contracts for construction for Mareesburg shortly," stated Ian Rozier.

Early in the quarter, a comprehensive internal safety review was conducted in line with new DMR (South African Department of Mineral Resources) general safety recommendations on roof support requirements. Following this review, support methods at CRM have been modified. This review has also accelerated the previously planned progressive introduction of cement grout support packs into working panels as mining operations at CRM get deeper and where support requirements are projected to increase. These measures should further enhance safety standards at CRM. This increase in support standards necessitated the retraining of underground personnel with a consequent temporary reduction in the number of working panels during the quarter that impacted on mine production. Following the decision taken early in 2010 to accelerate the development of reserves at CRM, development has increased for the fourth consecutive quarter. Concentrator recovery from ROM ore for the quarter increased to 79% compared to 78% in the quarter ended December 2010 as a result of improved concentrator utilization and stability. The increase in on reef development has impacted slightly on the head grade delivered to the plant.

http://www.halifaxmarketwatch.co.uk/rns.cgi?username=&ac=&action=news&rns=1&view=full&story_id=4179815

Interior Services Group (ISG) is the best looking new tip this week. Interior Services is now right on resistance that's been there for the past 3 years. A significant break above 215p would signal further moves upwards. Use an 11% stoploss from here. From David Linton of TipsTracker.com